Molecular Partners AG
- Biotech or pharma, therapeutic R&D
Molecular Partners (SIX, Nasdaq:MOLN) is pioneering a new class of therapeutics called DARPin, which we believe have the potential to overcome many limitations of current protein-based therapeutics and deliver entirely new ways of treating disease.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}